United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 29, 2015 | CEO | 2,592 | $134.25 | Sell | $347,976.00 | |
Sept. 24, 2015 | CEO | 9,662 | $139.26 | Sell | $1,345,530.12 | |
Sept. 23, 2015 | CEO | 2,211 | $142.05 | Sell | $314,072.55 | |
Sept. 21, 2015 | CEO | 2,592 | $150.81 | Sell | $390,899.52 | |
Sept. 17, 2015 | CEO | 9,662 | $152.02 | Sell | $1,468,817.24 | |
Sept. 16, 2015 | CEO | 2,211 | $151.93 | Sell | $335,917.23 | |
Sept. 14, 2015 | CEO | 2,592 | $153.08 | Sell | $396,783.36 | |
Sept. 10, 2015 | CEO | 4,115 | $152.95 | Sell | $629,389.25 | |
Sept. 9, 2015 | CEO | 2,211 | $152.77 | Sell | $337,774.47 | |
Sept. 8, 2015 | CEO | 2,592 | $152.80 | Sell | $396,057.60 | |
Sept. 3, 2015 | CEO | 9,662 | $153.67 | Sell | $1,484,759.54 | |
Sept. 3, 2015 | Director | 3,000 | $155.54 | Sell | $466,620.00 | |
Sept. 2, 2015 | CEO | 2,211 | $151.12 | Sell | $334,126.32 | |
Aug. 31, 2015 | CEO | 2,592 | $153.50 | Sell | $397,872.00 | |
Aug. 27, 2015 | CEO | 9,662 | $160.37 | Sell | $1,549,494.94 | |
Aug. 26, 2015 | CEO | 2,211 | $155.47 | Sell | $343,744.17 | |
Aug. 24, 2015 | CEO | 2,592 | $155.36 | Sell | $402,693.12 | |
Aug. 20, 2015 | CEO | 9,662 | $166.58 | Sell | $1,609,495.96 | |
Aug. 19, 2015 | CEO | 2,211 | $167.13 | Sell | $369,524.43 | |
Aug. 17, 2015 | CEO | 2,592 | $166.61 | Sell | $431,853.12 | |
Aug. 13, 2015 | CEO | 9,662 | $165.05 | Sell | $1,594,713.10 | |
July 27, 2015 | CEO | 2,592 | $166.38 | Sell | $431,256.96 | |
July 23, 2015 | CEO | 4,115 | $176.38 | Sell | $725,803.70 | |
July 22, 2015 | CEO | 2,211 | $174.55 | Sell | $385,930.05 | |
July 20, 2015 | CEO | 2,592 | $177.92 | Sell | $461,168.64 | |
July 16, 2015 | CEO | 9,662 | $175.51 | Sell | $1,695,777.62 | |
July 15, 2015 | CEO | 2,211 | $176.77 | Sell | $390,838.47 | |
July 13, 2015 | CEO | 2,592 | $172.42 | Sell | $446,912.64 | |
July 9, 2015 | CEO | 9,662 | $168.04 | Sell | $1,623,602.48 | |
July 8, 2015 | CEO | 2,211 | $167.13 | Sell | $369,524.43 | |
July 6, 2015 | CEO | 2,592 | $170.66 | Sell | $442,350.72 | |
July 2, 2015 | Director | 3,000 | $171.59 | Sell | $514,770.00 | |
July 2, 2015 | CEO | 6,326 | $170.69 | Sell | $1,079,784.94 | |
June 29, 2015 | CEO | 2,592 | $172.86 | Sell | $448,053.12 | |
June 25, 2015 | CEO | 9,662 | $176.91 | Sell | $1,709,304.42 | |
June 24, 2015 | CEO | 2,211 | $179.68 | Sell | $397,272.48 | |
June 22, 2015 | CEO | 2,592 | $188.64 | Sell | $488,954.88 | |
June 18, 2015 | CEO | 9,662 | $185.72 | Sell | $1,794,426.64 | |
June 18, 2015 | Director | 15,000 | $185.60 | Sell | $2,784,000.00 | |
June 17, 2015 | CEO | 2,211 | $185.25 | Sell | $409,587.75 | |
June 15, 2015 | CEO | 2,592 | $185.15 | Sell | $479,908.80 | |
June 11, 2015 | CEO | 9,662 | $183.76 | Sell | $1,775,489.12 | |
June 10, 2015 | CEO | 2,211 | $180.87 | Sell | $399,903.57 | |
June 8, 2015 | CEO | 2,592 | $181.34 | Sell | $470,033.28 | |
June 4, 2015 | Director | 3,000 | $181.36 | Sell | $544,080.00 | |
June 4, 2015 | CEO | 9,662 | $181.94 | Sell | $1,757,904.28 | |
June 3, 2015 | CEO | 2,211 | $184.49 | Sell | $407,907.39 | |
June 1, 2015 | CEO | 2,592 | $182.66 | Sell | $473,454.72 | |
May 28, 2015 | CEO | 9,662 | $180.88 | Sell | $1,747,662.56 | |
May 27, 2015 | CEO | 2,211 | $184.39 | Sell | $407,686.29 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.